Test Directory

Test Code
5429
Test Name
Kabuki Syndrome NGS Panel
CPT Codes
81479
Expected Turnaround Time
Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited.
Clinical Utility
Genetic analysis to provide a molecular diagnosis of this disorder. Recommended for individuals with a personal and/or family history of this disorder to ensure appropriate treatment and establish recurrence risk for family members.
Specimen and Container Info

Non-Prenatal Specimens

Preferred/Alternate

Specimen Type

Containers

Volume

Preferred Specimen Type

Whole Blood

Lavender Top (EDTA)

3 mL

Alternate Specimen Type

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

Alternate Specimen Type

Fibroblasts

T-25 Flasks

2 confluent T-25 flasks, filled to capacity

Alternate Specimen Type

Saliva (Whole blood is recommended for CNV)

DNA Self-Collection Kit or Oragene Saliva Collection Kit for Young Children

Follow kit instructions (www.dnagenotek.com)

Prenatal Specimens

Either specimen type below is acceptable.

Specimen Type

Containers

Volume

Cultured cells

T-25 Flasks

2 confluent T-25 flasks derived from amnio or CVS samples.

Genomic DNA

1.5 mL Tube

3 µg (at a concentration of at least 30 ng/µl), preferably in TE solution.

NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico.

Transport Instructions
  • Transport at room temperature within 24 hours.
  • If the specimen cannot be transported to the lab within 24 hours, refrigerate for up to 72 hours.
  • Do not freeze or expose to extreme temperatures, refrigerate for up to 72 hours if cannot be transported to lab within 24 hours. 
Stability Requirements

Room Temperature

24 hours

Refrigerated

72 hours

Causes for Rejection
  • Improperly labeled specimen (minimum of two patient identifiers)
  • Inappropriate specimen type
  • Incomplete or incorrect test request form
  • Insufficient volume
  • Specimen has leaked in transit
  • Specimen without a test order
Methodology
Next Generation Sequencing and Copy Number Variation Analysis
Performing Location
Genomics - Snowdrift
Description

Kabuki syndrome is genetically and clinically heterogeneous developmental disorder. Clinical findings include developmental delay, distinct facial features, cleft lip and/or palate, postnatal growth retardation, genitourinary anomalies, and skeletal findings such as scoliosis and congenital hip dislocations. Facial features long palpebral fissures with eversion of lateral third of lower eyelids, broad arched eyebrows with sparseness, short nasal columella with depressed nasal tip, and prominent or cupped ears. Congenital heart defects, ventricular septal defect, atrial septal defect, bicuspid aortic valve, and aortic coarctation are also relatively common findings. Most patients have mutations in the KDM6A or KMT2D gene. A few patients have been reported to have a mutation in the HNRNPK, RAP1A or RAP1B genes.

The Kabuki syndrome NGS panel consists of five genes: HNRNPK, KDM6A, KMT2D, RAP1A and RAP1B.

Gene

Disorder

MIM

Inheritance

HNRNPK

Au-Kline syndrome (AUKS)

Kabuki syndrome, HNRNPK related

616580

-

AD

AD

KDM6A

Kabuki syndrome 2 (KABUK2)

300867

XLD

KMT2D

Kabuki syndrome 1 (KABUK1)

147920

AD

RAP1A

Kabuki syndrome, RAP1A related

-

AR

RAP1B

Kabuki syndrome, RAP1B related

-

AD

Testing Schedule
Monday-Friday
Genes
HNRNPK, KDM6A, KMT2D, RAP1A, RAP1B
Disease Group
Cardiovascular Disorders, Craniosynostosis and Craniofacial Disorders, Dysmorphology, Neuromuscular, Skeletal Disorders